Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.
about
Weak stromal Caveolin-1 expression in colorectal liver metastases predicts poor prognosis after hepatectomy for liver-only colorectal metastases.Caveolin-1: An Oxidative Stress-Related Target for Cancer Prevention.Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Blood-brain barrier transport machineries and targeted therapy of brain diseases.SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer.Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy.Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer.Caveolin-1 Promotes the Imbalance of Th17/Treg in Patients with Chronic Obstructive Pulmonary Disease.Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases.
P2860
Q33700495-2E056D0C-608B-4D22-9F9E-ABD54502D2E5Q33701745-38124949-AEDC-40D1-A33F-79919165129AQ38658509-32978449-9094-430D-8591-49864BAEB71CQ38689014-ABF72915-5182-4908-AD40-7446C9A6DC56Q38742506-8417F878-11D3-4199-B1BF-AC7A2D87D992Q38847914-B28605C8-F373-4085-857E-179896CD281BQ39164804-F02A731A-DD58-430A-8CD2-DF26042D2254Q41642309-93BD4FD9-2D4B-43CC-B886-205E4232279EQ47782363-DF9D3A54-8FFD-47BD-97FD-A14213FED25AQ49882372-41968747-818F-47F1-BC4D-5FCBD91C1A85Q51457862-9B36D0A2-C486-4024-A2DC-7DE97EB3206DQ55401220-E0E6F05A-3437-4027-9291-D4A61CE75BB1
P2860
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stromal Caveolin-1 Is Associat ...... n for Advanced NSCLC Patients.
@en
Stromal Caveolin-1 Is Associat ...... n for Advanced NSCLC Patients.
@nl
type
label
Stromal Caveolin-1 Is Associat ...... n for Advanced NSCLC Patients.
@en
Stromal Caveolin-1 Is Associat ...... n for Advanced NSCLC Patients.
@nl
prefLabel
Stromal Caveolin-1 Is Associat ...... n for Advanced NSCLC Patients.
@en
Stromal Caveolin-1 Is Associat ...... n for Advanced NSCLC Patients.
@nl
P2093
P2860
P1433
P1476
Stromal Caveolin-1 Is Associat ...... in for Advanced NSCLC Patients
@en
P2093
Erin M Bertino
Gary S Phillips
Gregory A Otterson
Meliha Rahmani
Miguel A Villalona-Calero
Moumita Chatterjee
S Patrick Nana-Sinkam
Terence M Williams
Xiaokui Mo
P2860
P304
P356
10.1016/J.CLLC.2015.05.004
P407
P50
P577
2015-05-13T00:00:00Z